32 Recruiting Trials

Clinical Trials
for Kidney Disease in Illinois

32 clinical trials for Kidney Disease are currently recruiting participants at study sites in Illinois. Study-related care is provided at no cost.

32
Recruiting trials
36
Study sites
12
Cities
18
Industry-sponsored
10
Phase 2
10
Phase 3

Kidney Disease clinical trials in Illinois: what to expect

Kidney disease trials are mostly for chronic kidney disease that is slowly getting worse, including kidney disease caused by diabetes. They test medicines meant to slow the decline in kidney function and protect the heart, usually on top of the standard blood pressure and diabetes treatments. Specific kidney diseases such as IgA nephropathy, FSGS and polycystic kidney disease now have many trials of their own, and separate studies enroll people on dialysis or living with a transplant.

In Illinois, recruiting kidney disease studies are concentrated in Chicago, Rockford, Champaign and Evanston, with sites in 8 other cities. 18 of the 32 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who kidney disease trials usually look for

Trials describe kidney disease by two numbers: the filtration rate (eGFR) from a blood test and the amount of protein in the urine. Most enroll an eGFR between about 20 and 75 and a urine protein level above a cut-off, both measured at screening. Nearly all ask that you have taken a stable dose of a blood-pressure medicine of the ACE inhibitor or ARB type for three months, and many allow or require an SGLT2 inhibitor. IgA nephropathy and FSGS trials need a past kidney biopsy. Common exclusions are a transplant, dialysis and uncontrolled blood pressure.

What taking part involves

Screening includes blood and urine tests, sometimes a 24-hour urine collection, and a review of your records. Trials then run one to three years with visits every four to twelve weeks for labs and blood pressure, taking a study pill or injection added to your usual medicines; placebo arms are common and an extension often follows. Your nephrologist keeps managing your care. Study medicine and tests are free and visits are usually paid.

Questions worth asking the study team

Which stage the trial enrolls and whether you fit it; whether any of your medicines change; how often labs are needed; the chance of placebo; and whether you will be told your own kidney results during the study.

Showing 20 of 32 recruiting Kidney Disease trials in Illinois

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
PHASE3 Birmingham, Alabama +4 sites NCT07107945
This trial is looking for children aged 2 to 17 who have chronic kidney disease. Participants will take a daily tablet for 6 months followed by 1 year of another medication, with regular check-ups to monitor their health.
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
PHASE3 Huntsville, Alabama +4 sites NCT07753993
This trial is looking for adults with chronic kidney disease to see how well elecoglipron works compared to a placebo. Participants must be on certain medications for their condition before joining the study.
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
PHASE2 San Dimas, California +4 sites NCT06717698
This trial is looking for adults with chronic kidney disease, with or without type 2 diabetes, who are living with overweight or obesity. Participants will receive either a new medicine, a standard medicine, or a placebo for up to 43 weeks.
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
PHASE1 Chicago, Illinois +4 sites NCT07024823
This trial is looking for healthy individuals and those with chronic kidney disease and type 2 diabetes. Participants will take doses of AZD4248 and may also track their kidney function at home.
Recruiting
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
PHASE2 Huntsville, Alabama +4 sites NCT07271186
This trial is looking for adults with diabetic kidney disease to test some new medications. Participants will help researchers understand how safe and effective these medications are.
Recruiting
Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease
EARLY_PHASE1 Chicago, Illinois NCT06430684
This trial is looking for youth with chronic kidney disease (CKD) to see if a treatment called empagliflozin can help improve kidney and heart health. Participants will either receive this medication or continue their usual care for three months.
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3 Fairhope, Alabama +4 sites NCT06742723
This trial is looking for adults with chronic kidney disease and high blood pressure. If you join, you will take medications to see how they affect your kidney health and heart-related risks.
Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
PHASE2 Alabaster, Alabama +4 sites NCT05312879
This trial is looking for adults and children with a specific type of kidney disease caused by genetics. Participants will receive the drug VX-147 to assess its effectiveness and safety.
Recruiting
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
PHASE2 Huntsville, Alabama +4 sites NCT07355296
This trial is looking for adults and older teenagers with specific kidney diseases who have been stable on certain medications for at least a couple of months. They need to be in good enough health with manageable blood pressure. However, if you have had an organ transplant or recently used strong immunosuppressive treatments, you can't participate.
Recruiting
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PHASE2 Birmingham, Alabama +4 sites NCT06902558
This trial is looking for adults with a specific type of kidney disease. Participants will receive either the study drug or a placebo every 4 weeks for 92 weeks and will attend regular check-ups.
Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
PHASE2 Decatur, Alabama +4 sites NCT06830629
This trial is looking for adults with a specific genetic risk for kidney disease and ongoing protein in their urine. Participants will take the drug MZE829 to see how it affects their kidney condition.
Recruiting
Interactive Computer-adaptive Chronic Kidney Disease Education Program
NA Chicago, Illinois NCT06364358
This trial is looking for African-American patients aged 18 to 70 who are in the hospital and have advanced kidney disease. Participants will experience a computerized education program aiming to improve their understanding of kidney care.
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
PHASE3 Birmingham, Alabama +4 sites NCT06963827
This trial is looking for adults with a kidney condition called IgA nephropathy. Participants will receive either mezagitamab or a placebo for 22 weeks and then be monitored for about 1.5 years.
Recruiting
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
N/A Chicago, Illinois +4 sites NCT07059962
This trial is looking for adults with kidney disease who are on peritoneal dialysis. Participants will help explore a new way to predict health issues related to fluid overload.
Recruiting
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
NA Chicago, Illinois NCT06397456
This trial is looking for hospitalized Black or African American adults with advanced chronic kidney disease. Participants will receive special education and support for 12 weeks to help manage their condition.
Recruiting
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
PHASE3 Long Beach, California +4 sites NCT05931276
This trial is looking for patients on hemodialysis who take certain beta blockers. Participants will receive either metoprolol or carvedilol to see how these medications affect heart health.
Recruiting
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
N/A Chicago, Illinois +4 sites NCT05106387
This trial is looking for adult patients who have received a kidney transplant and were treated with vonsetamig in a previous study. Participants will be monitored to see how their body responds after the transplant, but no study drug will be given during this trial.
Recruiting
Early PKD Observational Cohort Study
N/A Chicago, Illinois +2 sites NCT02936791
This trial is looking for people with early-stage polycystic kidney disease (PKD), their healthy siblings, and normal volunteers. Participants will provide blood and urine samples and clinical information to help researchers understand the disease better.
Recruiting
Breakthrough - T1DM and Chronic Kidney Disease
PHASE1 Chicago, Illinois +1 sites NCT07592000
This trial is looking for adults with type 1 diabetes and chronic kidney disease to test a combination of new treatments. Participating involves receiving a treatment with Tegoprubart and undergoing regular monitoring for about 5 years.
Recruiting

Where the Kidney Disease studies are in Illinois

  • Research Site, Chicago5 trials
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago3 trials
  • Research Site, Rockford3 trials
  • Northwestern University Feinberg School of Medicine, Chicago2 trials
  • Research Site, Champaign2 trials
  • University of Chicago Medical Center, Chicago2 trials

Counts are recruiting studies listing at least one site in Illinois, from ClinicalTrials.gov, refreshed every two days.

Kidney Disease clinical trials in Illinois: common questions

How many Kidney Disease clinical trials are recruiting in Illinois?
TrialFinder currently lists 32 recruiting Kidney Disease clinical trials with study sites in Illinois. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Kidney Disease clinical trials located in Illinois?
Study sites for the Kidney Disease trials listed on this page include Chicago. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Kidney Disease clinical trial in Illinois?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Kidney Disease trials in Illinois also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Kidney Disease clinical trial in Illinois?
Each study sets its own criteria based on age, Kidney Disease diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
What stage of kidney disease do trials look for?
Trials state an eGFR range and a urine protein threshold rather than a stage name; most cover stages 2 to 4. People on dialysis or with a transplant have separate trials written for them.
Do I need a kidney biopsy to join?
Trials for IgA nephropathy, FSGS and lupus nephritis require a past biopsy confirming the diagnosis. Trials for diabetic or general chronic kidney disease do not.
Will I keep my current kidney and blood pressure medicines?
Yes. Kidney trials add the study treatment to a stable regimen, usually including an ACE inhibitor or ARB, and your own nephrologist continues to manage them.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Kidney Disease trials near you in Illinois.

Get Matched — Free
No insurance required

Kidney disease trials evaluate SGLT2 inhibitors, dialysis protocols, renal transplant regimens, and supportive-care strategies for chronic and acute kidney disease.

All Kidney Disease trials →